BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruffmann C, Bogliun G, Beghi E. Epileptogenic drugs: a systematic review. Expert Review of Neurotherapeutics 2014;6:575-89. [DOI: 10.1586/14737175.6.4.575] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Hohl CM, Stenekes S, Harlos MS, Shepherd E, Mcclement S, Chochinov HM. Methotrimeprazine for the management of End-Of-Life Symptoms in Infants and Children. J Palliat Care 2013;29:178-85. [DOI: 10.1177/082585971302900307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
2 Shah RR. Cardiac Effects of Antiepileptic Drugs. In: Panayiotopoulos CP, editor. Atlas of Epilepsies. London: Springer; 2010. pp. 1479-86. [DOI: 10.1007/978-1-84882-128-6_221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Berth-Jones J, Exton LS, Ladoyanni E, Mohd Mustapa MF, Tebbs VM, Yesudian PD, Levell NJ. British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018. Br J Dermatol 2019;180:1312-38. [PMID: 30653672 DOI: 10.1111/bjd.17587] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Holper S, Foster E, Chen Z, Kwan P. Emergency presentation of new onset versus recurrent undiagnosed seizures: A retrospective review. Emergency Medicine Australasia 2020;32:430-7. [DOI: 10.1111/1742-6723.13420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Huang X, McMahon J, Huang Y. Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy. Neuroscience 2012;215:90-7. [PMID: 22522471 DOI: 10.1016/j.neuroscience.2012.04.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
6 Van Cauwenberge MG, Dekeyzer S, Nikoubashman O, Dafotakis M, Wiesmann M. Can perfusion CT unmask postictal stroke mimics?: A case-control study of 133 patients. Neurology 2018;91:e1918-27. [DOI: 10.1212/wnl.0000000000006501] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 5.7] [Reference Citation Analysis]
7 Pedroviejo V, Ayuso M, Jiménez A. Tratamiento anestésico del paciente adulto epiléptico no neuroquirúrgico. Revista Española de Anestesiología y Reanimación 2009;56:425-35. [DOI: 10.1016/s0034-9356(09)70423-2] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Bloechliger M, Rüegg S, Jick SS, Meier CR, Bodmer M. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis. CNS Drugs 2015;29:591-603. [PMID: 26242478 DOI: 10.1007/s40263-015-0262-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
9 Clinckers R, Zgavc T, Vermoesen K, Meurs A, Michotte Y, Smolders I. Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures: Anticonvulsant hippocampal adrenoreceptors. Journal of Neurochemistry 2010;115:1595-607. [DOI: 10.1111/j.1471-4159.2010.07065.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
10 Zaccara G. Neurological comorbidity and epilepsy: implications for treatment. Acta Neurol Scand 2009;120:1-15. [PMID: 19527225 DOI: 10.1111/j.1600-0404.2008.01146.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
11 Ostroumova TM, Ostroumova OD, Akimova ES, Kochetkov AI. [Drug-induced seizures: prevalence, risk factors, treatment and prevention]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:86-97. [PMID: 31851178 DOI: 10.17116/jnevro201911911186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gruntz K, Bloechliger M, Becker C, Jick SS, Fuhr P, Meier CR, Rüegg S. Parkinson disease and the risk of epileptic seizures: PD and Epileptic Seizures. Ann Neurol 2018;83:363-74. [DOI: 10.1002/ana.25157] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
13 Alme KN, Engelsen BA, Naik M, Naess H. Identifying patients at risk of acute symptomatic seizure after ischemic stroke. Acta Neurol Scand 2017;136:265-71. [DOI: 10.1111/ane.12721] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
14 L'Amoreaux WJ, Marsillo A, El Idrissi A. Pharmacological characterization of GABAA receptors in taurine-fed mice. J Biomed Sci 2010;17 Suppl 1:S14. [PMID: 20804588 DOI: 10.1186/1423-0127-17-S1-S14] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
15 Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119-36. [PMID: 26043321 DOI: 10.1002/wps.20204] [Cited by in Crossref: 366] [Cited by in F6Publishing: 326] [Article Influence: 61.0] [Reference Citation Analysis]
16 Karceski S. Acute symptomatic seizures and systemic illness. Continuum (Minneap Minn) 2014;20:614-23. [PMID: 24893237 DOI: 10.1212/01.CON.0000450969.61204.6f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Winter MJ, Redfern WS, Hayfield AJ, Owen SF, Valentin J, Hutchinson TH. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. Journal of Pharmacological and Toxicological Methods 2008;57:176-87. [DOI: 10.1016/j.vascn.2008.01.004] [Cited by in Crossref: 122] [Cited by in F6Publishing: 112] [Article Influence: 9.4] [Reference Citation Analysis]
18 Mago R, Mahajan R, Thase ME. Medically serious adverse effects of newer antidepressants. Curr Psychiatry Rep 2008;10:249-57. [DOI: 10.1007/s11920-008-0041-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
19 Metea M, Litwak M, Arezzo J. Assessment of seizure risk in pre-clinical studies: Strengths and limitations of the electroencephalogram (EEG). Journal of Pharmacological and Toxicological Methods 2015;75:135-42. [DOI: 10.1016/j.vascn.2015.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
20 Bloechliger M, Ceschi A, Rüegg S, Jick SS, Meier CR, Bodmer M. Lifestyle factors, psychiatric and neurologic comorbidities, and drug use associated with incident seizures among adult patients with depression: a population-based nested case–control study. Eur J Epidemiol 2016;31:1113-22. [DOI: 10.1007/s10654-016-0156-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
21 Huang C, Feng L, Li Y, Wang Y, Chi X, Wang W, Hao N, Zhou D, Chen L. Clinical features and prognosis of epilepsy in the elderly in western China. Seizure 2016;38:26-31. [DOI: 10.1016/j.seizure.2016.03.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Walker MC, Kullmann DM. Optogenetic and chemogenetic therapies for epilepsy. Neuropharmacology 2020;168:107751. [PMID: 31494141 DOI: 10.1016/j.neuropharm.2019.107751] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
23 Habibi M, Hart F, Bainbridge J. The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs. Curr Neurol Neurosci Rep 2016;16. [DOI: 10.1007/s11910-016-0670-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
24 Bartolini E, Sander JW. Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy. Epilepsy & Behavior 2019;97:212-8. [DOI: 10.1016/j.yebeh.2019.05.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
25 Man KKC, Lau WCY, Coghill D, Besag FMC, Cross JH, Ip P, Wong ICK. Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study. Lancet Child Adolesc Health 2020;4:435-43. [PMID: 32450123 DOI: 10.1016/S2352-4642(20)30100-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
26 Glynn SM, Parent JM, Aminoff MJ. Seizures and General Medical Disorders. Aminoff's Neurology and General Medicine. Elsevier; 2014. pp. 1159-77. [DOI: 10.1016/b978-0-12-407710-2.00057-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 El Idrissi A, L'Amoreaux WJ. Selective resistance of taurine-fed mice to isoniazide-potentiated seizures: in vivo functional test for the activity of glutamic acid decarboxylase. Neuroscience 2008;156:693-9. [PMID: 18727952 DOI: 10.1016/j.neuroscience.2008.07.055] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
28 Assis TRD, Nascimento OJM, Costa G, Bacellar A. Antiepileptic drugs patterns in elderly inpatients in a Brazilian tertiary center, Salvador, Brazil. Arq Neuro-Psiquiatr 2014;72:874-80. [DOI: 10.1590/0004-282x20140151] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mula M. Pharmacological treatment of anxiety disorders in adults with epilepsy. Expert Opinion on Pharmacotherapy 2018;19:1867-74. [DOI: 10.1080/14656566.2018.1527905] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
30 Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, Tomson T, Hauser WA. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010;51:671-5. [DOI: 10.1111/j.1528-1167.2009.02285.x] [Cited by in Crossref: 393] [Cited by in F6Publishing: 297] [Article Influence: 35.7] [Reference Citation Analysis]
31 Parikh ND, Levitsky J. Hepatotoxicity and drug interactions in liver transplant candidates and recipients. Clin Liver Dis 2013;17:737-47, x-xi. [PMID: 24099028 DOI: 10.1016/j.cld.2013.07.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
32 Sáez ME, González-pérez A, Gaist D, Johansson S, Nagy P, García Rodríguez LA. Risk of seizure associated with use of acid-suppressive drugs: An observational cohort study. Epilepsy & Behavior 2016;62:72-80. [DOI: 10.1016/j.yebeh.2016.06.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Stephen LJ, Brodie MJ. Management of a first seizure. Special problems: adults and elderly. Epilepsia 2008;49 Suppl 1:45-9. [PMID: 18184155 DOI: 10.1111/j.1528-1167.2008.01450.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
34 Winter MJ, Pinion J, Tochwin A, Takesono A, Ball JS, Grabowski P, Metz J, Trznadel M, Tse K, Redfern WS, Hetheridge MJ, Goodfellow M, Randall AD, Tyler CR. Functional brain imaging in larval zebrafish for characterising the effects of seizurogenic compounds acting via a range of pharmacological mechanisms. Br J Pharmacol 2021;178:2671-89. [PMID: 33768524 DOI: 10.1111/bph.15458] [Reference Citation Analysis]